“Another measure looked at fibrosis, which is me
Post# of 145755
26% of 950 is 247 patients that experienced non progression of Fibrosis. Or I guess an improvement. It’s a little beyond me to compare that to Leronlimab. Without side by side top line comparisons.
Read More: https://investorshangout.com/post/view?id=651...z7o4iX7xw6
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)